{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T12:35:28Z","timestamp":1648643728248},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1093\/ndt\/gfl384","type":"journal-article","created":{"date-parts":[[2006,7,23]],"date-time":"2006-07-23T00:36:04Z","timestamp":1153614964000},"page":"2986-2987","source":"Crossref","is-referenced-by-count":1,"title":["Current treatment options in secondary hyperparathyroidism"],"prefix":"10.1093","volume":"21","author":[{"given":"Katherine","family":"Wesseling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,10]]},"reference":[{"key":"key\n\t\t\t\t20171012185519_B1","doi-asserted-by":"crossref","unstructured":"Reichel H.  (2006) Current treatment options in secondary renal hyperparathyroidism.  Nephrol Dial Transplant21:23\u201328.","DOI":"10.1093\/ndt\/gfi097"},{"key":"key\n\t\t\t\t20171012185519_B2","doi-asserted-by":"crossref","unstructured":"Kim HW, Park CW, Shin YS, et al.  (2006) Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.  Nephron Clin Pract102:c21\u2013c29.","DOI":"10.1159\/000088295"},{"key":"key\n\t\t\t\t20171012185519_B3","doi-asserted-by":"crossref","unstructured":"Salusky IB, Goodman WG, Sahney S, et al.  (2005) Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.  J Am Soc Nephrol16:2501\u20132508.","DOI":"10.1681\/ASN.2004100885"},{"key":"key\n\t\t\t\t20171012185519_B4","doi-asserted-by":"crossref","unstructured":"Chertow GM, Burke SK, Raggi P.  (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.  Kidney Int62:245\u2013252.","DOI":"10.1046\/j.1523-1755.2002.00434.x"},{"key":"key\n\t\t\t\t20171012185519_B5","doi-asserted-by":"crossref","unstructured":"Shoji T, Shinohara K, Kimoto E, et al.  (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.  Nephrol Dial Transplant19:179\u2013184.","DOI":"10.1093\/ndt\/gfg513"},{"key":"key\n\t\t\t\t20171012185519_B6","doi-asserted-by":"crossref","unstructured":"Henderson RG, Russell RG, Ledingham JG, et al.  (1974) Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.  Lancet1:379\u2013384.","DOI":"10.1016\/S0140-6736(74)93149-3"},{"key":"key\n\t\t\t\t20171012185519_B7","doi-asserted-by":"crossref","unstructured":"Panda DK, Miao D, Bolivar I, et al.  (2004) Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis.  J Biol Chem279:16754\u201316766.","DOI":"10.1074\/jbc.M310271200"},{"key":"key\n\t\t\t\t20171012185519_B8","doi-asserted-by":"crossref","unstructured":"Thomas MK, Lloyd-Jones DM, Thadhani RI, et al.  (1998) Hypovitaminosis D in medical inpatients.  N Engl J Med338:777\u2013783.","DOI":"10.1056\/NEJM199803193381201"},{"key":"key\n\t\t\t\t20171012185519_B9","doi-asserted-by":"crossref","unstructured":"Lips P, Wiersinga A, van Ginkel FC, et al.  (1988) The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects.  J Clin Endocrinol Metab67:644\u2013650.","DOI":"10.1210\/jcem-67-4-644"},{"key":"key\n\t\t\t\t20171012185519_B10","doi-asserted-by":"crossref","unstructured":"Cunningham J, Danese M, Olson K, Klassen P, Chertow GM.  (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.  Kidney Int68:1793\u20131800.","DOI":"10.1111\/j.1523-1755.2005.00596.x"},{"key":"key\n\t\t\t\t20171012185519_B11","doi-asserted-by":"crossref","unstructured":"Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D.  J Biol Chem  (2002)  277:30337\u201330350.","DOI":"10.1074\/jbc.M201804200"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/10\/2986\/7625123\/gfl384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T23:36:03Z","timestamp":1507851363000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/10\/2986\/1865815\/Current-treatment-options-in-secondary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":11,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2006,10]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl384","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,10]]},"published":{"date-parts":[[2006,10,1]]}}}